40 research outputs found
Fluorescence Monitoring and Parallel Factor Analysis of Contaminant Mixtures in Water
Pharmaceuticals and Personal Care Products (PPCPs) pollute our water systems regularly by entering the environment through inefficient methods of water treatment, ineffective sanitation and unregulated industrial and agricultural runoff. Currently, the most common methods of identifying PCPPs are expensive, time consuming and often require the aid of a trained expert. This project aims to further the methodology of utilizing fluorescence spectroscopy as a means of pollutant detection with a focus on contaminant mixtures. Four non-regulated EPA contaminants were fluoresced at compound specific EEM parameters and then again in two component mixtures to determine their limits of detection (LOD). The results were analyzed using Parallel Factor (PARAFAC) analysis to decrease the LOD. The results showed that the LOD of the fluorescence spectrometer could be lowered to environmentally relevant concentrations when paired with PARAFAC analysis. Compound mixtures were detected with equivalent precision and accuracy to single compound solutions. This validates fluorescent spectroscopy paired with PARAFAC analysis as a means of contaminant detection with greater speed, ease and economy. This would allow for real-time decisions concerning water safety which would globally add to the overall health of communities. Further studies should be done to test collected water samples and greater mixture complexity
Orientalismo e anticiganismo na cultura pop: conceitos para uma anĂĄlise de personagens femininas e masculinas
O presente artigo baseia-se na experiĂȘncia pedagĂłgica do Coletivo Hunna: Historiadoras que Dançam no curso âOrientalismo e Anticiganismo na Cultura Popâ. SĂŁo abordados os conceitos de Orientalismo e Anticiganismo, apresentando uma interpretação dos mesmos em relação aos estudos de gĂȘnero, demonstrando como hĂĄ uma leitura estereotipada do chamado Oriente e do mundo ĂĄrabe-islĂąmico, vinculando-a a elementos ditos femininos. Como possibilidade de aplicação dessa intersecção, analisamos personagens femininas e masculinas presentes em produtos da cultura pop, mais especificamente nos romances O Corcunda de Notre Dame (1831), de Victor Hugo, Carmen (1845) de Prosper MĂ©rimĂ©e, na animação Aladdin (1992), bem como no live action de mesmo tĂtulo (2019) dos estĂșdios Disney e, por fim, na novela O Clone (2001) produzida pela TV Globo
The Third Fermi Large Area Telescope Catalog of Gamma-ray Pulsars
We present 294 pulsars found in GeV data from the Large Area Telescope (LAT)
on the Fermi Gamma-ray Space Telescope. Another 33 millisecond pulsars (MSPs)
discovered in deep radio searches of LAT sources will likely reveal pulsations
once phase-connected rotation ephemerides are achieved. A further dozen optical
and/or X-ray binary systems co-located with LAT sources also likely harbor
gamma-ray MSPs. This catalog thus reports roughly 340 gamma-ray pulsars and
candidates, 10% of all known pulsars, compared to known before Fermi.
Half of the gamma-ray pulsars are young. Of these, the half that are undetected
in radio have a broader Galactic latitude distribution than the young
radio-loud pulsars. The others are MSPs, with 6 undetected in radio. Overall,
>235 are bright enough above 50 MeV to fit the pulse profile, the energy
spectrum, or both. For the common two-peaked profiles, the gamma-ray peak
closest to the magnetic pole crossing generally has a softer spectrum. The
spectral energy distributions tend to narrow as the spindown power
decreases to its observed minimum near erg s, approaching the
shape for synchrotron radiation from monoenergetic electrons. We calculate
gamma-ray luminosities when distances are available. Our all-sky gamma-ray
sensitivity map is useful for population syntheses. The electronic catalog
version provides gamma-ray pulsar ephemerides, properties and fit results to
guide and be compared with modeling results.Comment: 142 pages. Accepted by the Astrophysical Journal Supplemen
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported in single populations, with the majority of reports focused on White in Europe and North America. The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) has assembled data on 18,435 families with BRCA1 mutations and 11,351 families with BRCA2 mutations ascertained from 69 centers in 49 countries on six continents. This study comprehensively describes the characteristics of the 1,650 unique BRCA1 and 1,731 unique BRCA2 deleterious (disease-associated) mutations identified in the CIMBA database. We observed substantial variation in mutation type and frequency by geographical region and race/ethnicity. In addition to known founder mutations, mutations of relatively high frequency were identified in specific racial/ethnic or geographic groups that may reflect founder mutations and which could be used in targeted (panel) first pass genotyping for specific populations. Knowledge of the population-specific mutational spectrum in BRCA1 and BRCA2 could inform efficient strategies for genetic testing and may justify a more broad-based oncogenetic testing in some populations
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1,395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; and 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared with information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known nonpathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Abstract: Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCMâ/â patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors
The Science Performance of JWST as Characterized in Commissioning
This paper characterizes the actual science performance of the James Webb
Space Telescope (JWST), as determined from the six month commissioning period.
We summarize the performance of the spacecraft, telescope, science instruments,
and ground system, with an emphasis on differences from pre-launch
expectations. Commissioning has made clear that JWST is fully capable of
achieving the discoveries for which it was built. Moreover, almost across the
board, the science performance of JWST is better than expected; in most cases,
JWST will go deeper faster than expected. The telescope and instrument suite
have demonstrated the sensitivity, stability, image quality, and spectral range
that are necessary to transform our understanding of the cosmos through
observations spanning from near-earth asteroids to the most distant galaxies.Comment: 5th version as accepted to PASP; 31 pages, 18 figures;
https://iopscience.iop.org/article/10.1088/1538-3873/acb29
Modelling and predicting growth of psychrotolerant pseudomonads in milk and cottage cheese
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Abstract The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared to information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known non-pathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification. This article is protected by copyright. All rights reserved.Peer reviewe
The Barcelona Disputation: Texts and Contexts
Scholars of Jewish history have paid consistent and devoted attention to the Barcelona Disputation of 1263. Records of this event preserve contemporary Jewish and Christian responses to the proceedings, which pitted Nahmanides, the most important exegete and teacher of the region, against a convert from Judaism to Christianity, took place in the royal court before an illustrious audience. This essay traces trends in scholarly treatments of the Barcelona Disputation from the early days of the Wissenschaft des Judentums to the present. By examining challenges of veracity posed by the documentary sources as well as foundational assumptions about what the medieval authors intended to achieve with their accounts, this article provides broad overview of the historiography that has developed around the Barcelona Disputation